|
Market Closed -
Xetra
12:35:24 2026-10-28 EDT
|
After hours 14:39:21 | |||
| 19.16 EUR | +1.48% |
|
19.22 | +0.31% |
| 10-26 | Formycon AG : Berenberg gives a Buy rating | ZD |
| 10-21 | Formycon Partners with Biocelys to Develop Biosimilar Candidate | MT |
| Market Cap | 334M 372M 308M 279M 522M 35.42B 528M 3.69B 1.47B 18.53B 1.4B 1.37B 58.84B | P/E 2026 * |
581x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 448M 499M 414M 375M 701M 47.54B 709M 4.95B 1.97B 24.88B 1.87B 1.83B 78.98B | EV / Sales 2026 * |
6.16x | EV / Sales 2027 * | 3.99x |
| Free-Float |
69.59% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Xetra
| FYB | Delayed | |
Tradegate
| FYB | Real-time | |
|
Börse Stuttgart
| FYB | Delayed | |
|
CBOE
| FYBd | Real-time | |
|
Boerse Muenchen
| FYB | Real-time | |
|
Deutsche Boerse AG
| FYB | Delayed | |
|
CBOE
| 0W4N | Real-time | |
|
Berne S.E.
| FYB | End-of-day quote | |
|
Wiener Boerse
| FYB | End-of-day quote |
Last Transcript: Formycon AG
| 1 day | +1.85% | ||
| 1 week | -2.04% | ||
| Current month | -0.93% | ||
| 1 month | +1.16% | ||
| 3 months | +1.38% | ||
| 6 months | +6.33% | ||
| Current year | -25.16% |
| 1 week | 18.82 |  | 19.66 |
| 1 month | 18.3 | | 22.1 |
| Current year | 15.8 | | 26.95 |
| 1 year | 15.8 | | 26.95 |
| 3 years | 15.8 | | 67.8 |
| 5 years | 15.8 | | 94.1 |
| 10 years | 14.65 | | 94.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stefan Glombitza
CEO | Chief Executive Officer | - | 2022-06-30 |
Enno Spillner
DFI | Director of Finance/CFO | 57 | 2023-03-31 |
Andreas Seidl
CTO | Chief Tech/Sci/R&D Officer | - | 2022-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Klaus Röhrig
BRD | Director/Board Member | 49 | 2020-12-09 |
Wolfgang Essler
CHM | Chairman | 54 | 2024-06-11 |
Bodo Coldewey
BRD | Director/Board Member | 54 | 2024-06-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/21/25 | Buy | Chief Technology Officer | 160 | 0.0009% | ||
| 4/29/24 | Buy | Executive/Senior Manager | 1,200 | 0.0068% | ||
| 4/24/24 | Buy | Chief Executive Officer | 2,500 | 0.0142% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.48% | -2.04% | -15.22% | -64.58% | 372M | |
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +1.76% | +1.27% | +11.82% | +82.12% | 54.55B | |
| -0.94% | +0.99% | +10.45% | +102.18% | 53.59B | |
| +2.06% | +0.37% | +27.29% | +56.73% | 44.75B | |
| +2.34% | -3.01% | +18.30% | +100.87% | 41.62B | |
| +0.49% | -3.89% | +220.99% | +917.56% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +29.06% | +47.63% | +107.12% | +94.27% | 26.7B | |
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | |
| Average | +4.19% | -0.45% | +45.02% | +139.22% | 38.08B | |
| Weighted average by Cap. | +3.13% | -0.29% | +47.11% | +160.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 72.66M 80.98M 67.17M 60.84M 114M 7.71B 115M 803M 320M 4.04B 304M 297M 12.81B | 112M 125M 104M 93.82M 175M 11.89B 177M 1.24B 493M 6.22B 469M 459M 19.76B |
| Net income | 593K 661K 548K 497K 928K 62.95M 939K 6.56M 2.61M 32.94M 2.48M 2.43M 105M | 23.19M 25.85M 21.44M 19.42M 36.28M 2.46B 36.72M 256M 102M 1.29B 97M 94.95M 4.09B |
| Net Debt | 114M 127M 106M 95.62M 179M 12.12B 181M 1.26B 503M 6.34B 478M 468M 20.14B | 113M 126M 105M 94.95M 177M 12.04B 180M 1.25B 499M 6.3B 474M 464M 20B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-28 | €19.16 | +1.48% | 1,460 |
| 26-10-27 | €18.88 | -0.11% | 903 |
| 26-10-26 | €18.90 | +0.32% | 888 |
| 26-10-23 | €18.84 | -0.74% | 2,790 |
| 26-10-22 | €18.98 | -2.97% | 2,263 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FYB Stock
Select your edition
All financial news and data tailored to specific country editions
